Urovant Sciences Ltd. (UROV) is a publicly traded company in the Unknown sector. Across all available filings, 35 corporate insiders have executed 267 transactions totaling $412.7M, demonstrating a bullish sentiment with $409.6M in net insider flow. The most recent transaction on Mar 29, 2021 involved a transaction of 12,480 shares valued at $0.
No significant insider buying has been recorded for UROV in the recent period.
No significant insider selling has been recorded for UROV in the recent period.
Based on recent SEC filings, insider sentiment for UROV is bullish with an Insider Alignment Score of 100/100 and a net flow of $409.6M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Urovant Sciences Ltd. (UROV) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 35 insiders are actively trading UROV stock, having executed 267 transactions in the past 90 days. The most active insider is David C. Ott (Executive), who has made 3 transactions totaling $100.0M.
Get notified when executives and directors at UROV file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Mar 29, 2021 | S. Potter Myrtle | Executive | Disposition | 12,480 | $N/A | $0 | |
| Mar 29, 2021 | S. Potter Myrtle | Executive | Disposition | 9,000 | $N/A | $0 | |
| Mar 29, 2021 | Ocampo Christine | Executive | Disposition | 9,810 | $N/A | $0 | |
| Mar 29, 2021 | Ocampo Christine | Executive | Disposition | 68,971 | $N/A | $0 | |
| Mar 29, 2021 | E. Smith Bryan | Executive | Disposition | 9,341 | $N/A | $0 | |
| Mar 29, 2021 | E. Smith Bryan | Executive | Disposition | 115,106 | $N/A | $0 | |
| Mar 29, 2021 | Bansal Ajay | Executive | Disposition | 115,222 | $N/A | $0 | |
| Mar 29, 2021 | Bansal Ajay | Executive | Disposition | 24,876 | $N/A | $0 | |
| Mar 29, 2021 | M. Hindman James | Executive | Disposition | 9,000 | $N/A | $0 | |
| Mar 29, 2021 | Johnston Walt | Executive | Disposition | 492 | $N/A | $0 | |
| Mar 29, 2021 | Johnston Walt | Executive | Disposition | 108,647 | $N/A | $0 | |
| Mar 29, 2021 | Kurstjens Sef | Executive | Disposition | 12,480 | $N/A | $0 | |
| Mar 29, 2021 | Kurstjens Sef | Executive | Disposition | 9,000 | $N/A | $0 | |
| Mar 29, 2021 | Haag-molkenteller Cornelia | Executive | Disposition | 129,745 | $N/A | $0 | |
| Mar 29, 2021 | Haag-molkenteller Cornelia | Executive | Disposition | 11,603 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 219 | $411.1M | 98.5% |
Payment(F) | 5 | $2.1M | 0.5% |
Sale(S) | 2 | $1.5M | 0.4% |
Exercise(M) | 3 | $1.5M | 0.4% |
Other(J) | 2 | $1.2M | 0.3% |
Disposition(D) | 18 | $0 | 0.0% |
Award(A) | 18 | $0 | 0.0% |
Insiders at Urovant Sciences Ltd. are accumulating shares at an accelerated pace. With 35 insiders making 267 transactions totaling $411.1M in purchases versus $1.5M in sales, the net buying activity of $409.6M signals strong executive confidence. David C. Ott (Executive) leads the buying activity with $100.0M in transactions across all time.